Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
| Business Activity | PASS |
| Debt Ratio (0.33%) | PASS |
| Cash Ratio (0.00%) | PASS |
| Receivables Ratio (0.17%) | PASS |
| Revenue Ratio (0.00%) | PASS |
| Overall | PASS |
| Date | EPS Est. | Reported EPS | Surprise % |
|---|---|---|---|
| 2026-07-30 | 3.47 | Pending | -- |
| 2026-04-30 | 2.98 | 2.60 | -12.9% |
| 2026-01-29 | 4.40 | 4.47 | +1.7% |
| 2025-10-30 | 3.13 | 3.19 | +1.9% |
| 2025-07-31 | 3.07 | 3.13 | +1.9% |
| 2025-05-01 | 2.73 | 2.84 | +4.0% |
| 2025-01-28 | 3.87 | 4.01 | +3.5% |
| 2024-10-29 | 2.77 | 2.87 | +3.5% |
| Period | Revenue | Net Income | EBITDA | Gross Profit | Op. Income | EPS |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6.0B | $745.0M | $1.3B | $3.8B | $936.0M | 1.95 |
| 2025-12-31 | $7.2B | $849.0M | $2.2B | $4.6B | $1.8B | 2.21 |
| 2025-09-30 | $6.1B | $859.0M | $1.5B | $3.9B | $1.2B | 2.25 |
| 2025-06-30 | $6.0B | $884.0M | $1.5B | $3.8B | $1.2B | 2.32 |
| 2025-03-31 | $5.9B | $654.0M | $1.2B | $3.7B | $872.0M | 1.71 |
| Date | Name | Role | Shares | Value |
|---|---|---|---|---|
| 2026-05-11 | FINK MARY KATHRYN | Officer | 8,720 | $2.5M |
| 2026-05-08 | FINK MARY KATHRYN | Officer | 21,582 | $3.6M |
| 2026-05-06 | MACEDA EMMANUEL PEREZ | Director | 762 | -- |
| 2026-05-06 | KING DEBRA | Chief Technology Officer | 1,016 | -- |
| 2026-05-06 | SKEETE TATUM LISA M | Director | 762 | -- |
| 2026-05-06 | CAFORIO GIOVANNI | Director | 762 | -- |
| 2026-05-06 | RUGGERI RACHEL | Director | 762 | -- |
| 2026-05-06 | MONTAGNINO KIMBERLY ANN | Officer | 677 | -- |
| 2026-05-06 | STRYKER RONDA E | Director | 762 | -- |
| 2026-05-06 | SILVERNAIL ANDREW K. | Director | 762 | -- |
| Holder | Shares | Value | % Held |
|---|---|---|---|
| Blackrock Inc. | 27.6M | $8.7B | 0.1% |
| Vanguard Capital Management LLC | 22.4M | $7.1B | 0.1% |
| Greenleaf Trust | 15.9M | $5.0B | 0.0% |
| JPMORGAN CHASE & CO | 15.6M | $4.9B | 0.0% |
| State Street Corporation | 15.3M | $4.9B | 0.0% |
| Price (T.Rowe) Associates Inc | 10.0M | $3.2B | 0.0% |
| Vanguard Portfolio Management LLC | 8.3M | $2.6B | 0.0% |
| Wellington Management Group, LLP | 8.1M | $2.6B | 0.0% |
| Geode Capital Management, LLC | 7.7M | $2.5B | 0.0% |
| Morgan Stanley | 6.3M | $2.0B | 0.0% |
$133.6B
5.40
0.810
26
$25.3B
$15.2B
+14.2%
1.1%
1.76
2.30
0.0%
56,000
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| 2026-07-30 | $3.47 | Pending | — |
| 2026-04-30 | $2.98 | $2.60 | -12.9% |
| 2026-01-29 | $4.40 | $4.47 | +1.7% |
| 2025-10-30 | $3.13 | $3.19 | +1.9% |
| 2025-07-31 | $3.07 | $3.13 | +1.9% |
| 2025-05-01 | $2.73 | $2.84 | +4.0% |
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($389.35, 26 analysts) | |||
| 10 | $3,069.55 | +$823.90 (27%) | 1.8R |
| 50 | $15,347.75 | +$4,119.50 (27%) | 1.8R |
| 100 | $30,695.50 | +$8,239.00 (27%) | 1.8R |
| To Fair Value ($200.55) | |||
| 10 | $3,069.55 | +$-1,064.00 (-35%) | -2.3R |
| 50 | $15,347.75 | +$-5,320.00 (-35%) | -2.3R |
| 100 | $30,695.50 | +$-10,640.00 (-35%) | -2.3R |
- No elevated risk flags in current data
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| XLV | 0.581 |
| ISRG | 0.555 |
| MDT | 0.528 |
| SPRE | 0.507 |
| XLRE | 0.505 |
| Ticker | Correlation |
|---|---|
| LPTVQ | -0.197 |
| SUKOON.AE | -0.186 |
| VIA | -0.179 |
| BBLNF | -0.173 |
| WYFI | -0.173 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
After this company beats earnings, does the price keep going up? Drift tracks post-earnings momentum.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.